Science Explorer Back to mapMap
Discussion
Research facility · Oklahoma City · United States

Texas Oncology

In research, Texas Oncology stands highest in Health Sciences (#5,116 of 9,902 worldwide) and Medicine (#5,054 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Oncology (Oncology is 14.4× its share of world research).

texasoncology.comROR OpenAlex
World rank, 2022-now
#13,068
of 22,385 · #8,615 all time
Rank in United States
#1,834
of 3,332
Research works
1.2k
▲ 38% vs 2018-21
Citations
38k
30.6 per fractional work
Top-10% rate
11.9%
all institutions 10.0%
vs its own fields
0.95×
1.00× is exactly expected
Open access
28%
world 40%
International
17%
world 18%
Texas Oncology

What is Texas Oncology known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #5,116 of 9,902 14.1%149 #3770
MedicineField #5,054 of 8,541 14.5%143 #3779

Each strip is that field's whole ranked pool, with the notch where Texas Oncology sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Texas Oncology work in?

In 2022-now, 57% of research at Texas Oncology is in Health Sciences, 18% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (15%), Computer Science (11%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 171 fractional works · 57.0% of its workMedicine: 164 fractional works · 54.7% of its workOncology: 49 fractional works · 16.3% of its workPulmonary and Respiratory Medicine: 24 fractional works · 8.0% of its workRadiology, Nuclear Medicine and Imaging: 12 fractional works · 3.8% of its workPublic Health, Environmental and Occupational Health: 11 fractional works · 3.8% of its workPathology and Forensic Medicine: 9 fractional works · 2.9% of its workHematology: 8 fractional works · 2.5% of its workGenetics: 7 fractional works · 2.5% of its workSurgery: 7 fractional works · 2.4% of its workReproductive Medicine: 5 fractional works · 1.7% of its workEpidemiology: 5 fractional works · 1.7% of its workObstetrics and Gynecology: 4 fractional works · 1.4% of its workOphthalmology: 2 fractional works · 0.7% of its workHealth Informatics: 2 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 0.6% of its workPhysiology: 2 fractional works · 0.6% of its workFamily Practice: 2 fractional works · 0.6% of its workGeriatrics and Gerontology: 2 fractional works · 0.5% of its workNeurology: 1 fractional works · 0.5% of its workPsychiatry and Mental health: 1 fractional works · 0.4% of its workRheumatology: 1 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.3% of its workHepatology: 1 fractional works · 0.3% of its workImmunology and Allergy: 1 fractional works · 0.2% of its workOtorhinolaryngology: 1 fractional works · 0.2% of its workSmaller subfields together: 4 fractional works · 1.2% of its workHealth Professions: 6 fractional works · 1.9% of its workEmergency Medical Services: 2 fractional works · 0.6% of its workGeneral Health Professions: 2 fractional works · 0.6% of its workHealth Information Management: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.4% of its workNursing: 1 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.1% of its workLife Sciences: 54 fractional works · 18.1% of its workBiochemistry, Genetics and Molecular Biology: 44 fractional works · 14.5% of its workMolecular Biology: 19 fractional works · 6.4% of its workCancer Research: 15 fractional works · 4.9% of its workGenetics: 6 fractional works · 2.0% of its workBiotechnology: 2 fractional works · 0.7% of its workCell Biology: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workImmunology and Microbiology: 7 fractional works · 2.4% of its workImmunology: 7 fractional works · 2.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 2 fractional works · 0.6% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.4% of its workPharmacology: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 45 fractional works · 15.0% of its workComputer Science: 33 fractional works · 10.9% of its workInformation Systems: 18 fractional works · 5.9% of its workArtificial Intelligence: 9 fractional works · 2.8% of its workComputer Networks and Communications: 6 fractional works · 1.9% of its workSmaller subfields together: 1 fractional works · 0.3% of its workEngineering: 7 fractional works · 2.3% of its workBiomedical Engineering: 2 fractional works · 0.6% of its workElectrical and Electronic Engineering: 1 fractional works · 0.4% of its workIndustrial and Manufacturing Engineering: 1 fractional works · 0.4% of its workControl and Systems Engineering: 1 fractional works · 0.3% of its workBuilding and Construction: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.3% of its workEnvironmental Science: 2 fractional works · 0.5% of its workMaterials Science: 1 fractional works · 0.4% of its workPhysics and Astronomy: 1 fractional works · 0.4% of its workRadiation: 1 fractional works · 0.3% of its workChemistry: 1 fractional works · 0.3% of its workOrganic Chemistry: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMathematics: 1 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 29 fractional works · 9.8% of its workEconomics, Econometrics and Finance: 14 fractional works · 4.7% of its workEconomics and Econometrics: 14 fractional works · 4.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 6 fractional works · 2.1% of its workManagement Information Systems: 4 fractional works · 1.4% of its workManagement of Technology and Innovation: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.5% of its workSocial Sciences: 6 fractional works · 1.9% of its workSociology and Political Science: 2 fractional works · 0.8% of its workCultural Studies: 2 fractional works · 0.6% of its workSmaller subfields together: 2 fractional works · 0.5% of its workDecision Sciences: 2 fractional works · 0.8% of its workManagement Science and Operations Research: 2 fractional works · 0.5% of its workSmaller subfields together: 1 fractional works · 0.3% of its workPsychology: 1 fractional works · 0.3% of its workALL ITS WORKTexas Oncology300fractional works, 2022-now
Life Sciences18%Physical Sciences15%Health Sciences57%Social Sciences10%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine16454.7%
    2. Health Professions61.9%
    3. Nursing10.2%
    4. Dentistry00.1%
    1. Biochemistry, Genetics and Molecular Biology4414.5%
    2. Immunology and Microbiology72.4%
    3. Neuroscience20.6%
    4. Pharmacology, Toxicology and Pharmaceutics10.4%
    5. Agricultural and Biological Sciences00.1%
    1. Computer Science3310.9%
    2. Engineering72.3%
    3. Environmental Science20.5%
    4. Materials Science10.4%
    5. Physics and Astronomy10.4%
    6. Chemistry10.3%
    7. Mathematics10.3%
    8. Earth and Planetary Sciences00.1%
    1. Economics, Econometrics and Finance144.7%
    2. Business, Management and Accounting62.1%
    3. Social Sciences61.9%
    4. Decision Sciences20.8%
    5. Psychology10.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Texas Oncology specialise in?

Where its research is concentrated relative to its size: Oncology takes 14.4× the share of its output that it takes of world research.

  1. OncologySubfield · 48.8 works14×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.72× its world share, 44 worksBiochemistry, Geneti…Immunology and Microbiology: 2.43× its world share, 7 worksImmunology and Micro…Neuroscience: 0.39× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.14× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.21× its world share, 1 worksChemistryComputer Science: 1.40× its world share, 33 worksComputer ScienceEarth and Planetary Sciences: 0.04× its world share, 0 worksEarth and Planetary …Engineering: 0.15× its world share, 7 worksEngineeringEnvironmental Science: 0.10× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.10× its world share, 1 worksMaterials ScienceMathematics: 0.23× its world share, 1 worksMathematicsPhysics and Astronomy: 0.16× its world share, 1 worksPhysics and AstronomyDentistry: 0.24× its world share, 0 worksDentistryHealth Professions: 0.73× its world share, 6 worksHealth ProfessionsMedicine: 2.85× its world share, 164 worksMedicineNursing: 0.44× its world share, 1 worksNursingBusiness, Management and Accounting: 0.66× its world share, 6 worksBusiness, Management…Decision Sciences: 0.84× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 2.21× its world share, 14 worksEconomics, Econometr…Psychology: 0.09× its world share, 1 worksPsychologySocial Sciences: 0.15× its world share, 6 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 2.9×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Medicine2.85×164 works
  2. Biochemistry, Genetics and Molecular Biology2.72×44 works
  3. Immunology and Microbiology2.43×7 works
  4. Economics, Econometrics and Finance2.21×14 works
  5. Computer Science1.40×33 works
  6. Pharmacology, Toxicology and Pharmaceutics1.14×1 works
  7. Decision Sciences0.84×2 works
  8. Health Professions0.73×6 works
  9. Business, Management and Accounting0.66×6 works
  10. Nursing0.44×1 works
  11. Neuroscience0.39×2 works
  12. Dentistry0.24×0 works
  13. Mathematics0.23×1 works
  14. Chemistry0.21×1 works
  15. Physics and Astronomy0.16×1 works
  16. Engineering0.15×7 works
  17. Social Sciences0.15×6 works
  18. Environmental Science0.10×2 works
  19. Materials Science0.10×1 works
  20. Psychology0.09×1 works
  21. Earth and Planetary Sciences0.04×0 works
  22. Agricultural and Biological Sciences0.03×0 works

Who are the top researchers at Texas Oncology?

Ranked on the quality score, Thomas E. Hutson, Joyce A O'Shaughnessy and Debra A. Patt lead among researchers whose main affiliation is Texas Oncology.

  1. 1 Thomas E. Hutson United States · #65,076 worldwide 52k citations · 413 works
  2. 2 Joyce A O'Shaughnessy United States · #78,465 worldwide 27k citations · 453 works
  3. 3 Debra A. Patt United States · #100,276 worldwide 10k citations · 238 works
  4. 4 Joyce O’Shaughnessy United States · #113,121 worldwide 23k citations · 661 works
  5. 5 Donald Richards United States · #182,235 worldwide 17k citations · 384 works
  6. 6 Kristi J. McIntyre United States · #238,010 worldwide 7k citations · 79 works
  7. 7 Sharon T. Wilks United States · #243,354 worldwide 4.6k citations · 87 works
  8. 8 Andrew Scott Paulson United States · #245,313 worldwide 6.7k citations · 186 works
  9. 9 Joanne L. Blum United States · #328,411 worldwide 4.2k citations · 74 works
  10. 10 Charles Lance Cowey United States · #398,611 worldwide 23k citations · 110 works
All ranked researchers at Texas Oncology

What are the most cited papers from Texas Oncology?

The most cited paper from Texas Oncology is "Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma" (Robert John Motzer, Thomas E. Hutson, Piotr Tomczak et al., 2007), with 5,801 citations. Next come "Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma" (5,453) and "Abiraterone and Increased Survival in Metastatic Prostate Cancer" (4,448).

Most cited papers
#PaperReleasedCitations
1 Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma Robert John Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine Open access 10 Jan 2007 5,801
2 Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma Jedd D. Wolchok et al. · New England Journal of Medicine Open access 11 Sep 2017 5,453
3 Abiraterone and Increased Survival in Metastatic Prostate Cancer Johann Sebastian De Bono et al. · New England Journal of Medicine Open access 25 May 2011 4,448
4 Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo et al. · New England Journal of Medicine Open access 4 Jun 2018 3,816
5 Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma James Larkin et al. · New England Journal of Medicine Open access 28 Sep 2019 3,784
All 60 most cited papers, with filters and sorting

Which keywords describe research at Texas Oncology?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Breast Cancer, Immunotherapy, Metastatic Breast Cancer, Tumor Microenvironment, Prognostic Factors, Targeted Therapy and Clinical Trials.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy29▲ 13×21 topics
  2. Breast Cancer24▲ 31×11 topics
  3. Immunotherapy20▲ 9.0×17 topics
  4. Metastatic Breast Cancer16▲ 87×2 topics
  5. Tumor Microenvironment15▲ 11×8 topics
  6. Big Data14▲ 4.9×8 topics
  7. Prognostic Factors14▲ 11×14 topics
  8. Targeted Therapy14▲ 20×5 topics
  9. Clinical Trials13▲ 6.7×12 topics
  10. Cancer13▲ 3.2×32 topics
  11. Quality of Life12▲ 2.9×20 topics
  12. Cancer Therapy12▲ 6.7×14 topics
  13. Survival Analysis11▲ 14×7 topics
  14. Clinical Practice Guidelines11▲ 6.8×12 topics
  15. Metastatic11▲ 55×2 topics
  16. Distributed Systems11▲ 21×3 topics
  17. Cloud Computing11▲ 12×4 topics
  18. Cell Cycle Control10▲ 103×2 topics
  19. Metastasis10▲ 10×10 topics
  20. CDK4/6 Inhibitors10▲ 120×1 topic
  21. Palbociclib10▲ 120×1 topic
  22. Precision Medicine10▲ 6.5×6 topics
  23. Cost of Care10▲ 106×1 topic
  24. Financial Toxicity10▲ 106×1 topic
  25. Radiotherapy9▲ 7.9×11 topics
  26. Neoadjuvant Therapy9▲ 13×5 topics
  27. Trastuzumab9▲ 59×2 topics
  28. Rituximab9▲ 20×4 topics
  29. Receptor tyrosine kinases8▲ 73×2 topics
  30. Resource Management8▲ 17×2 topics
  31. EGFR8▲ 87×1 topic
  32. HER28▲ 87×1 topic
  33. Lymphoma8▲ 17×3 topics
  34. Monoclonal Antibody8▲ 51×2 topics
  35. MapReduce8▲ 46×1 topic
  36. Virtualization8▲ 33×1 topic
  37. PET Imaging8▲ 16×4 topics
  38. Molecular Subtypes8▲ 29×3 topics
  39. Molecular Characterization8▲ 14×4 topics
  40. Immune Checkpoint Blockade7▲ 22×1 topic

Which research topics does Texas Oncology publish most on?

By volume in 2022-now: Advanced Breast Cancer Therapies, Economic and Financial Impacts of Cancer, HER2/EGFR in Cancer Research and Cloud Computing and Resource Management.

Advanced Breast Cancer T…10Advanced Breast Cancer Therapies: 10 fractional worksEconomic and Financial I…10Economic and Financial Impacts of Cancer: 10 fractional worksHER2/EGFR in Cancer Rese…8HER2/EGFR in Cancer Research: 8 fractional worksCloud Computing and Reso…8Cloud Computing and Resource Management: 8 fractional worksCancer Immunotherapy and Biomarkers: 7 fractional worksCancer Genomics and Diagnostics: 7 fractional worksCancer Treatment and Pha…5Cancer Treatment and Pharmacology: 5 fractional worksBreast Cancer Treatment Studies: 5 fractional worksOvarian cancer diagnosis and treatment: 5 fractional worksChronic Lymphocytic Leukemia Research: 5 fractional works
Pulmonary and Respiratory MedicineEconomics and EconometricsOncologyInformation Systems3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 10 works
  2. 2 Economic and Financial Impacts of Cancer Economics and Econometrics 10 works
  3. 3 HER2/EGFR in Cancer Research Oncology 8 works
  4. 4 Cloud Computing and Resource Management Information Systems 8 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 7 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 7 works
  7. 7 Cancer Treatment and Pharmacology Oncology 5 works
  8. 8 Breast Cancer Treatment Studies Cancer Research 5 works
  9. 9 Ovarian cancer diagnosis and treatment Reproductive Medicine 5 works
  10. 10 Chronic Lymphocytic Leukemia Research Genetics 5 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.0%not open72.0%

World: 40% of research is openly available.

with international co-authors16.6%domestic only83.4%

World: 18% is written across borders.

How has Texas Oncology's research output changed?

Output in 2022-2025 was 38% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Texas Oncology as a percentage of every work published that year, 0.0012% in 2024.

still counting0.0010%0.0020%0.0030%Texas Oncology0.0011% in 202519801990200020102020

Fractional works of Texas Oncology over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%all institutions10.0% in 2025Texas Oncology8.9% in 202520102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 18.9% in 2010.

Other research institutions in Oklahoma City

All research institutions in Oklahoma City

Share Texas Oncology's ranking

Texas Oncology on Science Explorer

A card with Texas Oncology's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Texas Oncology. Posts are plain text and can be reported.